MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Eton Pharmaceuticals, Inc (NASDAQ: ETON)*
Organization & Developments: Eton
Parents
Eton Pharmaceuticals, Inc (NASDAQ: ETON)*
Children
2019: A Small Bet On Eton Pharmaceuticals_seekingalpha.com
2020: Our Take On Eton Pharmaceuticals
2020: The company has one approved therapy (Biorphen) and another eight late-stage candidates, four of which are under FDA review
2021: Another Look At Eton Pharmaceuticals
2022: Eton Pharmaceuticals: Alkindi Sprinkle Leads Growth In Orphan Disease Portfolio_ seekingalpha.com
2022: FDA approved ZONISADE (zonisamide oral suspension) to treat epilepsy
2025: Eton Pharmaceuticals Set To Dominate Orphan Drug Niche
Jumps
Finance & Acquisitions: Eton
Key People: Eton